BioMarin Pharmaceutical Inc (BMRN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:BioMarin Pharmaceutical Inc (BMRN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7155
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
BioMarin Pharmaceutical Inc (BioMarin) is a biopharmaceutical company which develops and commercializes innovative pharmaceuticals for treatment of serious diseases and medical conditions, such as Kyndrisa (drisapersen), Duchenne muscular dystrophy (DMD), phenylketonuria (PKU), achondroplasia, late infantile neuronal ceroid lipofuscinosis (CLN2) and hemophilia A. Its product category consists of multiple clinical and preclinical offerings. The company operates through its manufacturing facilities in Novato, California. It conducts its buisiness operations in the US, Europe, Latin America, the Middle East, and Asia-Pacific. BioMarin is headquartered in San Rafael, California, the US.

BioMarin Pharmaceutical Inc (BMRN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioMarin Pharmaceutical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
BioMarin Pharmaceutical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
BioMarin Pharmaceutical Inc, Medical Equipment, Deal Details 10
Partnerships 10
Zacharon Enters Into Licensing Agreement With Shire For Sensi Pro Assay 10
Equity Offering 11
BioMarin Pharma Raises USD720 Million in Public Offering of Shares 11
BioMarin Pharma Completes Public Offering Of Shares For US$119.3 Million 13
Debt Offering 14
BioMarin Pharma Completes Underwriters Exercise of Over-Allotment Option of 0.599% Notes Due 2024 for USD45 Million 14
BioMarin Pharma Completes Public Offering Of Notes Due 2020 For US$375 Million 15
BioMarin Pharma Completes Public Offering Of Notes Due 2018 For US$375 Million 17
Acquisition 19
Roche Rumored to Acquire BioMarin Pharma for USD13.5 Billion 19
BioMarin Pharma Acquires Zacharon Pharma For USD9.7 Million 20
BioMarin Pharmaceutical Inc – Key Competitors 21
BioMarin Pharmaceutical Inc – Key Employees 22
BioMarin Pharmaceutical Inc – Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Joint Venture 24
Recent Developments 25
Financial Announcements 25
Aug 02, 2018: BioMarin announces second quarter 2018 results 25
Apr 25, 2018: BioMarin Announces First Quarter 2018 Financial Results 28
Feb 22, 2018: BioMarin Reports Fourth Quarter 2017 Financial Results 31
Oct 26, 2017: BioMarin Announces Third Quarter 2017 Financial Results 34
Aug 02, 2017: BioMarin Announces Second Quarter 2017 Financial Results 38
May 04, 2017: BioMarin Announces First Quarter 2017 Financial Results 40
Feb 23, 2017: BioMarin Announces Fourth Quarter and Full Year 2016 Financial Results 42
Corporate Communications 44
Oct 03, 2017: BioMarin Appoints Robert J. Hombach, Former Baxalta CFO and COO, to Board of Directors 44
Appendix 45
Methodology 45
About GlobalData 45
Contact Us 45
Disclaimer 45

List of Tables
BioMarin Pharmaceutical Inc, Medical Equipment, Key Facts, 2017 2
BioMarin Pharmaceutical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioMarin Pharmaceutical Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioMarin Pharmaceutical Inc, Deals By Market, 2012 to YTD 2018 8
BioMarin Pharmaceutical Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Zacharon Enters Into Licensing Agreement With Shire For Sensi Pro Assay 10
BioMarin Pharma Raises USD720 Million in Public Offering of Shares 11
BioMarin Pharma Completes Public Offering Of Shares For US$119.3 Million 13
BioMarin Pharma Completes Underwriters Exercise of Over-Allotment Option of 0.599% Notes Due 2024 for USD45 Million 14
BioMarin Pharma Completes Public Offering Of Notes Due 2020 For US$375 Million 15
BioMarin Pharma Completes Public Offering Of Notes Due 2018 For US$375 Million 17
Roche Rumored to Acquire BioMarin Pharma for USD13.5 Billion 19
BioMarin Pharma Acquires Zacharon Pharma For USD9.7 Million 20
BioMarin Pharmaceutical Inc, Key Competitors 21
BioMarin Pharmaceutical Inc, Key Employees 22
BioMarin Pharmaceutical Inc, Subsidiaries 23
BioMarin Pharmaceutical Inc, Joint Venture 24

List of Figures
BioMarin Pharmaceutical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
BioMarin Pharmaceutical Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
BioMarin Pharmaceutical Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
BioMarin Pharmaceutical Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[BioMarin Pharmaceutical Inc (BMRN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Exxon Mobil Corporation:企業の戦略・SWOT・財務情報
    Exxon Mobil Corporation - Strategy, SWOT and Corporate Finance Report Summary Exxon Mobil Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • QPS Austria GmbH-製薬・医療分野:企業M&A・提携分析
    Summary QPS Austria GmbH (QPS), a subsidiary of QPS Holdings LLC, is a contract research organization that performs preclinical and clinical research. The company offers in vivo services which involves generating, characterizing and maintaining transgenic disease models and use them for drug testing …
  • Michael Foods, Inc.:企業の戦略・SWOT・財務情報
    Michael Foods, Inc. - Strategy, SWOT and Corporate Finance Report Summary Michael Foods, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Mitsui E&S Holdings Co., Ltd. (7003):企業の財務・戦略的SWOT分析
    Mitsui E&S Holdings Co., Ltd. (7003) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Dollar Tree Inc:戦略・SWOT・企業財務分析
    Dollar Tree Inc - Strategy, SWOT and Corporate Finance Report Summary Dollar Tree Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Trovagene Inc (TROV)-製薬・医療分野:企業M&A・提携分析
    Summary Trovagene Inc (Trovagene) is a development stage molecular diagnostic company focusing on the development and commercialization of proprietary molecular genetic detection technologies for screening and monitoring cancer and other diseases. Its product portfolio includes liquid biopsy tests t …
  • Engie SA (ENGI):企業の財務・戦略的SWOT分析
    Engie SA (ENGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • ProAxsis Ltd:企業の製品パイプライン分析2018
    Summary ProAxsis Ltd (ProAxsis), formerly ProAx-Sis Ltd, a subsidiary of NetScientific UK Ltd, is a developer of novel, point of care tests for the monitoring of patients with chronic diseases. The company develops proteasetags based point of care tests to offer a visual readout of active proteases …
  • United Food Holdings Limited:戦略・SWOT・企業財務分析
    United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary United Food Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Trimble Inc (TRMB):企業の財務・戦略的SWOT分析
    Trimble Inc (TRMB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Syncardia Systems LLC:医療機器:M&Aディール及び事業提携情報
    Summary Syncardia Systems LLC (SynCardia), a subsidiary of Versa Capital Management, Inc. develops and manufactures artificial human heart. Its flagship product, SynCardia temporary Total Artificial Heart (TAH-t) temporarily takes up the complete function of a failed human heart in patients sufferin …
  • Nokia Corp (NOKIA):企業の財務・戦略的SWOT分析
    Nokia Corp (NOKIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Ittehad Chemicals Ltd (ICL):企業の財務・戦略的SWOT分析
    Ittehad Chemicals Ltd (ICL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Natsionalna Elektricheska Kompania EAD:企業の戦略的SWOT分析
    Natsionalna Elektricheska Kompania EAD - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Core-Mark Holding Company, Inc. (CORE):企業の財務・戦略的SWOT分析
    Core-Mark Holding Company, Inc. (CORE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Jardine Lloyd Thompson Group plc:企業の戦略・SWOT・財務分析
    Jardine Lloyd Thompson Group plc - Strategy, SWOT and Corporate Finance Report Summary Jardine Lloyd Thompson Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Real Matters Inc (REAL):企業の財務・戦略的SWOT分析
    Real Matters Inc (REAL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Charles River Laboratories International Inc (CRL):医療機器:M&Aディール及び事業提携情報
    Summary Charles River Laboratories International Inc (Charles River) is a contract research organization (CRO) that provides essential products and services to accelerate the research, drug discovery and development. It offers various basic research, drug discovery and safety assessment services. Th …
  • Taylor Wessing LLP:企業の戦略・SWOT・財務情報
    Taylor Wessing LLP - Strategy, SWOT and Corporate Finance Report Summary Taylor Wessing LLP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Young & Co.’s Brewery, P.L.C. (YNGA):企業の財務・戦略的SWOT分析
    Young & Co.'s Brewery, P.L.C. (YNGA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆